The global smartsyringes market is expected to reach USD
10.2 billion in 2024, according to a new report by Grand View Research, Inc. In
2015, Some key factors driving the market include the rise in the patient
population, the increasing number of needle stick injuries, and the spread of
diseases due to unhygienic injection practices.
The injection practices and
healthcare delivery standards are not uniform across the globe. The use of
disposable syringes has been strongly advocated by various healthcare
organizations across different countries; however, adherence to the patient
safety guidelines is not adequately implemented in the LMIC (Low and Middle
Income Countries).
As per the WHO records, the
re-usage of syringes has boosted the infection cases of Ebola, malaria, Marburg
virus, HIV, hepatitis, and other diseases in LMIC; these countries have been
suffering with a huge infectious diseases burden due to the high transmission
rates of blood-borne virus infections. Increasing awareness regarding the usage
of smart syringes with safety mechanisms amongst the patients and the
healthcare providers is anticipated to fuel the expansion of the smart syringes
market over the forecast period.
As per the data published by
the U.S. Occupational Safety and Health Administration (OSHA), nearly 5.6
million workers in the healthcare sector are at a high risk of occupational
exposure to blood-borne pathogens, mainly on account of needle stick injuries
and other metal injuries. The data also indicates that on an average 1,000
injuries occur per day in the U.S. hospitals, which translates to 385,000
needle stick and other injuries per year.
Some previously reported
outbreaks due to the re-use of syringes include the following:
·
In 2007, hepatitis C outbreak
in Nevada, U.S.
·
In 2009, more than 400 people
were infected with Hepatitis B in Gujarat, India
·
In 2014, a group of more than
200 people(children and adults) living near Battambang, Cambodia, tested
positive for HIV
Hence, in order to improve the
healthcare outcomes and reduce the burden of infections, the healthcare
practitioners and hospitals are expected to adopt the usage of smart
syringes,which would significantly boost the smart syringes market over the
forecast period.
Full Research Report On smart syringes market Analysis:www.grandviewresearch.com/industry-analysis/smart-syringes-market
Further key findings from the study suggest:
·
In 2015, the auto-disable
syringes segment dominated the smart syringes market with revenue of over USD 3.0
billion. The established presence of the auto-disable syringes in the market is
one of the crucial reasons for its high share.
·
The passive safety syringes
segment is expected to emerge as the fastest growing market during the forecast
period
·
North America accounted for the
largest share in 2015 on account of very high healthcare standards, the
presence of well-developed hospital and primary healthcare networks, high
patient awareness, and the rising demand for sophisticated drug delivery
techniques.
·
Asia Pacific is identified as
the most lucrative market. Increase in the disease burden, the rising
population levels, and the growing demand for vaccination are the key market
drivers in this region. Furthermore, high investments to improve the patient
care services and to curb the risk of needle stick infections are expected to
spur the smart syringes market over the forecast period.
·
Some key players of the market
include Medtronic Plc (Covidien), Terumo Medical Corporation, Braun Melsungen
AG, Unilife Corporation, Becton, Dickinson and Co., Revolutions Medical
Corporation, Baxter International, Inc., Retractable Technologies, Inc., and
Smiths Group plc.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the smart
syringes market by product, application, end-use, and region:
Smart Syringes Product Outlook,
(USD Million, 2013 - 2024)
·
Auto-disable syringes
·
Active safety syringes
·
Passive safety syringes
Smart Syringes Application
Outlook, (USD Million,2013 - 2024)
·
Drug delivery
·
Vaccination
·
Blood specimen collection
Smart Syringes End-Use Outlook,
(USD Million,2013 - 2024)
·
Hospitals and HMOs
·
Diabetic patients
·
Family practices (Physicians)
·
Psychiatrists
·
Others
Smart Syringes Regional
Outlook, (USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Full Press Release of this Report: www.grandviewresearch.com/press-release/global-smart-syringes-market
About Grand
View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
